These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2721545)

  • 1. Transcutaneous absorption of naproxen gel.
    van den Ouweland FA; Eenhoorn PC; Tan Y; Gribnau FW
    Eur J Clin Pharmacol; 1989; 36(2):209-11. PubMed ID: 2721545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and local tissue disposition studies of naproxen-following topical and systemic administration in dogs and rats.
    Suh H; Jun HW; Dzimianski MT; Lu GW
    Biopharm Drug Dispos; 1997 Oct; 18(7):623-33. PubMed ID: 9330782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
    Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
    Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel organogels for topical delivery of naproxen: design, physicochemical characteristics and in vitro drug permeation.
    Osmałek T; Milanowski B; Froelich A; Górska S; Białas W; Szybowicz M; Kapela M
    Pharm Dev Technol; 2017 Jun; 22(4):521-536. PubMed ID: 26786600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of concurrent sucralfate administration on pharmacokinetics of naproxen.
    Caille G; du Souich P; Gervais P; Besner JG; Vezina M
    Am J Med; 1987 Sep; 83(3B):67-73. PubMed ID: 3661612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
    Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone and Transcutol.
    Escobar-Chávez JJ; Quintanar-Guerrero D; Ganem-Quintanar A
    Drug Dev Ind Pharm; 2005 May; 31(4-5):447-54. PubMed ID: 16093210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of single-dose administration of naproxen at 10:00 and 22:00 hours.
    Rao BR; Rambhau D; Rao VV
    Chronobiol Int; 1993 Apr; 10(2):137-42. PubMed ID: 8500190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of liposomes on transdermal permeation of naproxen--in vitro studies.
    Szura D; Ozimek Ł; Przybyło M; Karłowicz-Bodalska K; Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Han S
    Acta Pol Pharm; 2014; 71(1):145-51. PubMed ID: 24779203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a controlled release preparation of naproxen.
    Strocchi E; Ambrosioni E; Palazzini E; Galli G
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):253-6. PubMed ID: 1889910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of a new controlled-release oral naproxen formulation given with and without food.
    Palazzini E; Cristofori M; Babbini M
    Int J Clin Pharmacol Res; 1992; 12(4):179-84. PubMed ID: 1297641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of food and sucralfate on the pharmacokinetics of naproxen and ketoprofen in humans.
    Caillé G; du Souich P; Besner JG; Gervais P; Vézina M
    Am J Med; 1989 Jun; 86(6A):38-44. PubMed ID: 2735334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel.
    Seth BL
    Arzneimittelforschung; 1992 Feb; 42(2):120-2. PubMed ID: 1610419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic evaluation of compressed naproxen suppositories in humans.
    Sastry MS; Diwan PV
    Arzneimittelforschung; 1993 Nov; 43(11):1209-10. PubMed ID: 8292066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of Naproxen Sodium Gel Using Piper cubeba for Enhanced Transdermal Drug Delivery and Therapeutic Facilitation.
    Patwardhan S; Patil M; Sockalingam A
    Recent Pat Drug Deliv Formul; 2017; 11(1):28-35. PubMed ID: 28056749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release and skin permeation studies of Naproxen from hydrophillic gels and effect of terpenes as enhancers on its skin permeation.
    Ray S; Ghosal SK
    Boll Chim Farm; 2003 Apr; 142(3):125-9. PubMed ID: 12806832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability, food effect and tolerability of S-naproxen betainate sodium salt monohydrate in steady state.
    Marzo A; Dal Bo L; Wool C; Cerutti R
    Arzneimittelforschung; 1998 Sep; 48(9):935-40. PubMed ID: 9793622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig.
    Harboe E; Larsen C; Johansen M; Olesen HP
    Pharm Res; 1989 Nov; 6(11):919-23. PubMed ID: 2480587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and relative bioavailability of a fixed-dose combination of enteric-coated naproxen and non-enteric-coated esomeprazole magnesium.
    Wang-Smith L; Fort J; Zhang Y; Sostek M
    J Clin Pharmacol; 2012 May; 52(5):670-80. PubMed ID: 21628602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naproxen metabolism in man.
    Segre EJ
    J Clin Pharmacol; 1975 Apr; 15(4 Pt. 2):316-23. PubMed ID: 1127135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.